However, it is yet too early to conclude which is the precise origin of TDP-43 pathogenic signaling and how it differs from other ALS-associated genetic risks such as SOD1, FUS or C9orf72, as there are still major gaps in our current understanding of the underlying disease mechanisms. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.